Frequencies for first 10,000 rows of indi_pt variable in indi2012q1 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL DISCOMFORT | 6 0.06 0.06 ABDOMINAL PAIN | 5 0.05 0.11 ABDOMINAL PAIN UPPER | 4 0.04 0.15 ABDOMINOPLASTY | 1 0.01 0.16 ABNORMAL BEHAVIOUR | 5 0.05 0.21 ABORTION INDUCED | 2 0.02 0.23 ABSCESS | 1 0.01 0.24 ACCIDENTAL EXPOSURE | 2 0.02 0.26 ACINETOBACTER INFECTION | 2 0.02 0.28 ACNE | 60 0.60 0.88 ACNE CONGLOBATA | 1 0.01 0.89 ACNE CYSTIC | 2 0.02 0.91 ACROMEGALY | 7 0.07 0.98 ACUTE CORONARY SYNDROME | 12 0.12 1.10 ACUTE GRAFT VERSUS HOST DISEASE | 4 0.04 1.14 ACUTE LYMPHOCYTIC LEUKAEMIA | 3 0.03 1.17 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT | 9 0.09 1.26 ACUTE MYELOID LEUKAEMIA | 8 0.08 1.34 ACUTE MYOCARDIAL INFARCTION | 7 0.07 1.41 ADENOCARCINOMA | 1 0.01 1.42 ADENOCARCINOMA PANCREAS | 6 0.06 1.48 ADRENAL INSUFFICIENCY | 2 0.02 1.50 ADULT T-CELL LYMPHOMA/LEUKAEMIA | 1 0.01 1.51 ADVERSE DRUG REACTION | 1 0.01 1.52 AFFECTIVE DISORDER | 9 0.09 1.61 AGE-RELATED MACULAR DEGENERATION | 17 0.17 1.78 AGGRESSION | 5 0.05 1.83 AGITATION | 5 0.05 1.88 AGORAPHOBIA | 1 0.01 1.89 ALBRIGHT'S DISEASE | 1 0.01 1.90 ALOPECIA | 4 0.04 1.94 AMYLOIDOSIS | 2 0.02 1.96 ANAEMIA | 9 0.09 2.05 ANAEMIA OF MALIGNANT DISEASE | 1 0.01 2.06 ANAEMIA VITAMIN B12 DEFICIENCY | 1 0.01 2.07 ANAESTHESIA | 7 0.07 2.14 ANAL CANDIDIASIS | 2 0.02 2.16 ANAL FISTULA | 3 0.03 2.19 ANALGESIC THERAPY | 20 0.20 2.39 ANAPHYLAXIS PROPHYLAXIS | 1 0.01 2.40 ANDROGENETIC ALOPECIA | 1 0.01 2.41 ANGER | 1 0.01 2.42 ANGINA PECTORIS | 20 0.20 2.62 ANGINA UNSTABLE | 4 0.04 2.66 ANGIOGRAM | 2 0.02 2.68 ANGIOMYOLIPOMA | 1 0.01 2.69 ANGIOPATHY | 2 0.02 2.71 ANKYLOSING SPONDYLITIS | 21 0.21 2.92 ANTACID THERAPY | 1 0.01 2.93 ANTASTHMATIC DRUG LEVEL | 1 0.01 2.94 ANTI-INFECTIVE THERAPY | 1 0.01 2.95 ANTIBIOTIC PROPHYLAXIS | 27 0.27 3.22 ANTIBIOTIC THERAPY | 2 0.02 3.24 ANTICOAGULANT THERAPY | 12 0.12 3.36 ANTIDEPRESSANT THERAPY | 3 0.03 3.39 ANTIEMETIC SUPPORTIVE CARE | 1 0.01 3.40 ANTIFUNGAL PROPHYLAXIS | 14 0.14 3.54 ANTIFUNGAL TREATMENT | 2 0.02 3.56 ANTIINFLAMMATORY THERAPY | 5 0.05 3.61 ANTIPLATELET THERAPY | 1 0.01 3.62 ANTIRETROVIRAL THERAPY | 7 0.07 3.69 ANTIVIRAL PROPHYLAXIS | 19 0.19 3.88 ANURIA | 1 0.01 3.89 ANXIETY | 77 0.77 4.66 ANXIETY DISORDER | 4 0.04 4.70 ANXIOLYTIC THERAPY | 1 0.01 4.71 AORTIC DISSECTION | 2 0.02 4.73 AORTIC THROMBOSIS | 1 0.01 4.74 AORTIC VALVE REPLACEMENT | 1 0.01 4.75 APATHY | 2 0.02 4.77 APLASIA PURE RED CELL | 1 0.01 4.78 APLASTIC ANAEMIA | 24 0.24 5.02 ARRHYTHMIA | 9 0.09 5.11 ARRHYTHMIA PROPHYLAXIS | 1 0.01 5.12 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 5.13 ARTERIOSCLEROSIS | 1 0.01 5.14 ARTERITIS | 2 0.02 5.16 ARTHRALGIA | 11 0.11 5.27 ARTHRITIS | 30 0.30 5.57 ARTHRITIS BACTERIAL | 1 0.01 5.58 ARTHRODESIS | 1 0.01 5.59 ARTHROGRAM | 3 0.03 5.62 ARTHROPATHY | 2 0.02 5.64 ARTHROSCOPY | 1 0.01 5.65 ASPERGILLOSIS | 6 0.06 5.71 ASSISTED FERTILISATION | 1 0.01 5.72 ASTHENIA | 1 0.01 5.73 ASTHMA | 90 0.90 6.63 ASTHMA EXERCISE INDUCED | 2 0.02 6.65 ATOPY | 1 0.01 6.66 ATRIAL FIBRILLATION | 112 1.12 7.78 ATRIAL FLUTTER | 3 0.03 7.81 ATRIAL THROMBOSIS | 1 0.01 7.82 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 26 0.26 8.08 ATYPICAL MYCOBACTERIAL INFECTION | 1 0.01 8.09 AUTISM | 1 0.01 8.10 AUTOIMMUNE DISORDER | 1 0.01 8.11 AUTOIMMUNE HEPATITIS | 1 0.01 8.12 AUTOIMMUNE NEUTROPENIA | 6 0.06 8.18 AUTOIMMUNE THROMBOCYTOPENIA | 6 0.06 8.24 AUTOIMMUNE THYROIDITIS | 1 0.01 8.25 AUTOLOGOUS BONE MARROW TRANSPLANTATIO.. | 1 0.01 8.26 B PRECURSOR TYPE ACUTE LEUKAEMIA | 9 0.09 8.35 B-CELL LYMPHOMA | 10 0.10 8.45 BACK DISORDER | 3 0.03 8.48 BACK PAIN | 47 0.47 8.95 BACTERIAL INFECTION | 4 0.04 8.99 BALLISMUS | 1 0.01 9.00 BARRETT'S OESOPHAGUS | 2 0.02 9.02 BEHCET'S SYNDROME | 12 0.12 9.14 BENIGN PROSTATIC HYPERPLASIA | 19 0.19 9.33 BILIARY CANCER METASTATIC | 2 0.02 9.35 BIPOLAR DISORDER | 37 0.37 9.72 BIPOLAR I DISORDER | 9 0.09 9.81 BLADDER CANCER | 7 0.07 9.88 BLADDER CANCER STAGE 0, WITH CANCER I.. | 1 0.01 9.89 BLADDER DISORDER | 3 0.03 9.92 BLADDER IRRITATION | 2 0.02 9.94 BLADDER PROLAPSE | 1 0.01 9.95 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA | 1 0.01 9.96 BLEPHARITIS | 1 0.01 9.97 BLISTER | 1 0.01 9.98 BLOOD ANTIDIURETIC HORMONE DECREASED | 1 0.01 9.99 BLOOD CHOLESTEROL | 12 0.12 10.11 BLOOD CHOLESTEROL ABNORMAL | 7 0.07 10.18 BLOOD CHOLESTEROL INCREASED | 63 0.63 10.81 BLOOD CORTICOTROPHIN DECREASED | 1 0.01 10.82 BLOOD DISORDER | 1 0.01 10.83 BLOOD FOLLICLE STIMULATING HORMONE DE.. | 1 0.01 10.84 BLOOD GLUCOSE INCREASED | 1 0.01 10.85 BLOOD LUTEINISING HORMONE DECREASED | 1 0.01 10.86 BLOOD MAGNESIUM | 1 0.01 10.87 BLOOD POTASSIUM DECREASED | 2 0.02 10.89 BLOOD PRESSURE | 22 0.22 11.11 BLOOD PRESSURE ABNORMAL | 12 0.12 11.23 BLOOD PRESSURE INCREASED | 5 0.05 11.28 BLOOD TESTOSTERONE DECREASED | 1 0.01 11.29 BLOOD TESTOSTERONE INCREASED | 1 0.01 11.30 BLOOD THYROID STIMULATING HORMONE DEC.. | 1 0.01 11.31 BLOOD TRIGLYCERIDES | 2 0.02 11.33 BLOOD TRIGLYCERIDES ABNORMAL | 1 0.01 11.34 BLOOD TRIGLYCERIDES INCREASED | 7 0.07 11.41 BONE DENSITY ABNORMAL | 1 0.01 11.42 BONE DENSITY DECREASED | 1 0.01 11.43 BONE DISORDER | 3 0.03 11.46 BONE GRAFT | 1 0.01 11.47 BONE LESION | 2 0.02 11.49 BONE LOSS | 1 0.01 11.50 BONE MARROW CONDITIONING REGIMEN | 20 0.20 11.70 BONE MARROW TRANSPLANT | 1 0.01 11.71 BONE NEOPLASM MALIGNANT | 1 0.01 11.72 BONE PAIN | 8 0.08 11.80 BORDERLINE PERSONALITY DISORDER | 6 0.06 11.86 BREAKTHROUGH PAIN | 2 0.02 11.88 BREAST CANCER | 101 1.01 12.89 BREAST CANCER METASTATIC | 19 0.19 13.08 BREAST CANCER RECURRENT | 1 0.01 13.09 BRONCHIAL CARCINOMA | 1 0.01 13.10 BRONCHIAL DISORDER | 1 0.01 13.11 BRONCHIAL HYPERREACTIVITY | 2 0.02 13.13 BRONCHIECTASIS | 1 0.01 13.14 BRONCHITIS | 22 0.22 13.36 BRONCHITIS CHRONIC | 5 0.05 13.41 BRONCHOPNEUMONIA | 3 0.03 13.44 BRONCHOPULMONARY ASPERGILLOSIS | 4 0.04 13.48 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC | 3 0.03 13.51 BURKITT'S LYMPHOMA | 7 0.07 13.58 BURSITIS | 1 0.01 13.59 CANCER PAIN | 15 0.15 13.74 CANDIDIASIS | 2 0.02 13.76 CARCINOID SYNDROME | 1 0.01 13.77 CARCINOID TUMOUR | 7 0.07 13.84 CARCINOID TUMOUR OF THE GASTROINTESTI.. | 1 0.01 13.85 CARDIAC DISORDER | 18 0.18 14.03 CARDIAC FAILURE | 29 0.29 14.32 CARDIAC FAILURE CONGESTIVE | 4 0.04 14.36 CARDIAC OPERATION | 1 0.01 14.37 CARDIAC PACEMAKER INSERTION | 2 0.02 14.39 CARDIAC STRESS TEST | 4 0.04 14.43 CARDIOVASCULAR DISORDER | 4 0.04 14.47 CARDIOVASCULAR EVENT PROPHYLAXIS | 8 0.08 14.55 CATARACT | 1 0.01 14.56 CELLULITIS | 8 0.08 14.64 CENTRAL OBESITY | 1 0.01 14.65 CENTRAL PAIN SYNDROME | 1 0.01 14.66 CEREBRAL ARTERY OCCLUSION | 2 0.02 14.68 CEREBRAL HAEMORRHAGE | 1 0.01 14.69 CEREBRAL INFARCTION | 7 0.07 14.76 CEREBRAL OEDEMA MANAGEMENT | 1 0.01 14.77 CEREBROVASCULAR ACCIDENT | 6 0.06 14.83 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 10 0.10 14.93 CEREBROVASCULAR DISORDER | 1 0.01 14.94 CERVIX CARCINOMA | 4 0.04 14.98 CHELATION THERAPY | 1 0.01 14.99 CHEMOTHERAPY | 11 0.11 15.10 CHEST PAIN | 5 0.05 15.15 CHRONIC GRAFT VERSUS HOST DISEASE | 2 0.02 15.17 CHRONIC HEPATITIS | 1 0.01 15.18 CHRONIC LYMPHOCYTIC LEUKAEMIA | 5 0.05 15.23 CHRONIC MYELOID LEUKAEMIA | 37 0.37 15.60 CHRONIC MYELOID LEUKAEMIA (IN REMISSI.. | 1 0.01 15.61 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 47 0.47 16.08 CHRONIC SINUSITIS | 1 0.01 16.09 CHYLOTHORAX | 2 0.02 16.11 CIRCULATORY COLLAPSE | 2 0.02 16.13 CLAUSTROPHOBIA | 2 0.02 16.15 CLOSTRIDIAL INFECTION | 3 0.03 16.18 COAGULOPATHY | 4 0.04 16.22 COGNITIVE DISORDER | 3 0.03 16.25 COLITIS | 1 0.01 16.26 COLITIS ULCERATIVE | 24 0.24 16.50 COLON CANCER | 9 0.09 16.59 COLON CANCER METASTATIC | 11 0.11 16.70 COLON CANCER RECURRENT | 3 0.03 16.73 COLORECTAL CANCER | 3 0.03 16.76 COLORECTAL CANCER METASTATIC | 5 0.05 16.81 COMPLEX PARTIAL SEIZURES | 2 0.02 16.83 COMPUTERISED TOMOGRAM | 3 0.03 16.86 COMPUTERISED TOMOGRAM HEAD | 1 0.01 16.87 CONDUCT DISORDER | 2 0.02 16.89 CONFUSIONAL STATE | 1 0.01 16.90 CONGESTIVE CARDIOMYOPATHY | 1 0.01 16.91 CONJUNCTIVITIS | 1 0.01 16.92 CONSTIPATION | 34 0.34 17.26 CONSTIPATION PROPHYLAXIS | 3 0.03 17.29 CONTRACEPTION | 216 2.16 19.45 CONVULSION | 36 0.36 19.81 CORONARY ARTERIAL STENT INSERTION | 3 0.03 19.84 CORONARY ARTERY BYPASS | 1 0.01 19.85 CORONARY ARTERY DISEASE | 21 0.21 20.06 CORONARY ARTERY THROMBOSIS | 1 0.01 20.07 COUGH | 5 0.05 20.12 CROHN'S DISEASE | 122 1.22 21.34 CUSHING'S SYNDROME | 5 0.05 21.39 CYST | 1 0.01 21.40 CYSTIC FIBROSIS | 4 0.04 21.44 CYSTIC FIBROSIS RELATED DIABETES | 1 0.01 21.45 CYSTITIS INTERSTITIAL | 2 0.02 21.47 CYTOMEGALOVIRUS INFECTION | 1 0.01 21.48 DECREASED APPETITE | 5 0.05 21.53 DECREASED INTEREST | 2 0.02 21.55 DEEP VEIN THROMBOSIS | 5 0.05 21.60 DEFICIENCY ANAEMIA | 1 0.01 21.61 DELUSION | 2 0.02 21.63 DEMENTIA | 18 0.18 21.81 DEMENTIA ALZHEIMER'S TYPE | 7 0.07 21.88 DEPRESSED MOOD | 5 0.05 21.93 DEPRESSION | 158 1.58 23.51 DEPRESSION SUICIDAL | 1 0.01 23.52 DERMATITIS | 1 0.01 23.53 DESMOPLASTIC SMALL ROUND CELL TUMOUR | 1 0.01 23.54 DEVICE THERAPY | 4 0.04 23.58 DIABETES MELLITUS | 235 2.35 25.93 DIABETES MELLITUS MANAGEMENT | 2 0.02 25.95 DIABETIC NEUROPATHY | 2 0.02 25.97 DIARRHOEA | 12 0.12 26.09 DIFFUSE LARGE B-CELL LYMPHOMA | 55 0.55 26.64 DISEASE COMPLICATION | 1 0.01 26.65 DISSEMINATED INTRAVASCULAR COAGULATION | 1 0.01 26.66 DISTURBANCE IN ATTENTION | 3 0.03 26.69 DIURETIC THERAPY | 1 0.01 26.70 DIVERTICULITIS | 3 0.03 26.73 DIZZINESS | 2 0.02 26.75 DRUG ABUSE | 2 0.02 26.77 DRUG DEPENDENCE | 3 0.03 26.80 DRUG ERUPTION | 1 0.01 26.81 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 3 0.03 26.84 DRUG THERAPY | 3 0.03 26.87 DRY EYE | 1 0.01 26.88 DUODENAL ULCER | 2 0.02 26.90 DWARFISM | 1 0.01 26.91 DYSFUNCTIONAL UTERINE BLEEDING | 2 0.02 26.93 DYSLIPIDAEMIA | 22 0.22 27.15 DYSMENORRHOEA | 14 0.14 27.29 DYSPEPSIA | 8 0.08 27.37 DYSPNOEA | 4 0.04 27.41 DYSURIA | 3 0.03 27.44 EAR DISORDER | 1 0.01 27.45 EAR INFECTION | 5 0.05 27.50 EAR PAIN | 1 0.01 27.51 ECZEMA | 1 0.01 27.52 EJACULATION DISORDER | 1 0.01 27.53 EMBOLIC STROKE | 3 0.03 27.56 EMBOLISM | 1 0.01 27.57 EMPHYSEMA | 6 0.06 27.63 ENCEPHALITIS | 1 0.01 27.64 ENDOCARDITIS | 7 0.07 27.71 ENDOCRINE NEOPLASM MALIGNANT | 1 0.01 27.72 ENDOMETRIAL CANCER | 2 0.02 27.74 ENDOMETRIOSIS | 4 0.04 27.78 EPILEPSY | 125 1.25 29.03 ERECTILE DYSFUNCTION | 19 0.19 29.22 ERYTHEMA ANNULARE | 1 0.01 29.23 ESSENTIAL HYPERTENSION | 9 0.09 29.32 EX-TOBACCO USER | 1 0.01 29.33 EXPOSURE VIA SEMEN | 1 0.01 29.34 EYE DISORDER | 1 0.01 29.35 FABRY'S DISEASE | 2 0.02 29.37 FACTOR VIII DEFICIENCY | 1 0.01 29.38 FAECES HARD | 1 0.01 29.39 FATIGUE | 2 0.02 29.41 FEBRILE NEUTROPENIA | 3 0.03 29.44 FEMUR FRACTURE | 1 0.01 29.45 FIBROMYALGIA | 18 0.18 29.63 FLATULENCE | 1 0.01 29.64 FLUID REPLACEMENT | 2 0.02 29.66 FLUID RETENTION | 4 0.04 29.70 FOETAL EXPOSURE DURING PREGNANCY | 27 0.27 29.97 FOLATE DEFICIENCY | 2 0.02 29.99 FRACTURE | 3 0.03 30.02 FRONTAL LOBE EPILEPSY | 1 0.01 30.03 FUNGAL INFECTION | 3 0.03 30.06 FUNGAL SKIN INFECTION | 1 0.01 30.07 FURUNCLE | 1 0.01 30.08 GAIT DISTURBANCE | 1 0.01 30.09 GASTRIC BANDING | 1 0.01 30.10 GASTRIC CANCER | 17 0.17 30.27 GASTRIC CANCER RECURRENT | 3 0.03 30.30 GASTRIC DISORDER | 7 0.07 30.37 GASTRIC HYPOMOTILITY | 1 0.01 30.38 GASTRIC PH DECREASED | 1 0.01 30.39 GASTRIC ULCER | 10 0.10 30.49 GASTRITIS | 13 0.13 30.62 GASTRITIS PROPHYLAXIS | 9 0.09 30.71 GASTROINTESTINAL CARCINOMA | 2 0.02 30.73 GASTROINTESTINAL STROMAL TUMOUR | 14 0.14 30.87 GASTROOESOPHAGEAL REFLUX DISEASE | 51 0.51 31.38 GENERAL ANAESTHESIA | 8 0.08 31.46 GENERAL PHYSICAL HEALTH DETERIORATION | 1 0.01 31.47 GENERALISED ANXIETY DISORDER | 1 0.01 31.48 GENITAL LABIAL ADHESIONS | 2 0.02 31.50 GESTATIONAL DIABETES | 8 0.08 31.58 GLAUCOMA | 16 0.16 31.74 GLIOBLASTOMA | 1 0.01 31.75 GLIOBLASTOMA MULTIFORME | 1 0.01 31.76 GLOMERULONEPHRITIS | 1 0.01 31.77 GLOMERULONEPHRITIS MEMBRANOUS | 2 0.02 31.79 GLUCOSE TOLERANCE IMPAIRED | 1 0.01 31.80 GOUT | 13 0.13 31.93 GOUTY ARTHRITIS | 2 0.02 31.95 GRAFT VERSUS HOST DISEASE | 6 0.06 32.01 GRAND MAL CONVULSION | 1 0.01 32.02 GROWTH HORMONE DEFICIENCY | 4 0.04 32.06 GROWTH RETARDATION | 1 0.01 32.07 H1N1 INFLUENZA | 1 0.01 32.08 HAEMANGIOMA | 1 0.01 32.09 HAEMATOCRIT DECREASED | 1 0.01 32.10 HAEMATURIA | 1 0.01 32.11 HAEMOCHROMATOSIS | 2 0.02 32.13 HAEMOPHILIA | 2 0.02 32.15 HAEMORRHAGE | 1 0.01 32.16 HAEMORRHAGE PROPHYLAXIS | 2 0.02 32.18 HAEMORRHOIDS | 1 0.01 32.19 HALLUCINATION | 6 0.06 32.25 HALLUCINATION, AUDITORY | 5 0.05 32.30 HEAD AND NECK CANCER | 7 0.07 32.37 HEADACHE | 27 0.27 32.64 HEART DISEASE CONGENITAL | 1 0.01 32.65 HEART RATE INCREASED | 1 0.01 32.66 HEART RATE IRREGULAR | 2 0.02 32.68 HEART TRANSPLANT REJECTION | 1 0.01 32.69 HELICOBACTER GASTRITIS | 3 0.03 32.72 HEPATIC CIRRHOSIS | 5 0.05 32.77 HEPATIC FUNCTION ABNORMAL | 3 0.03 32.80 HEPATIC NEOPLASM | 1 0.01 32.81 HEPATIC NEOPLASM MALIGNANT | 30 0.30 33.11 HEPATITIS | 1 0.01 33.12 HEPATITIS B | 5 0.05 33.17 HEPATITIS C | 81 0.81 33.98 HEREDITARY ANGIOEDEMA | 5 0.05 34.03 HERPES ZOSTER | 4 0.04 34.07 HIATUS HERNIA | 1 0.01 34.08 HICCUPS | 2 0.02 34.10 HIGH DENSITY LIPOPROTEIN DECREASED | 1 0.01 34.11 HIGH DENSITY LIPOPROTEIN INCREASED | 1 0.01 34.12 HIP ARTHROPLASTY | 1 0.01 34.13 HIP SURGERY | 1 0.01 34.14 HIRSUTISM | 2 0.02 34.16 HIV INFECTION | 41 0.41 34.57 HODGKIN'S DISEASE | 7 0.07 34.64 HORMONE LEVEL ABNORMAL | 1 0.01 34.65 HORMONE REPLACEMENT THERAPY | 22 0.22 34.87 HOT FLUSH | 1 0.01 34.88 HYPERAMMONAEMIA | 1 0.01 34.89 HYPERCALCAEMIA | 3 0.03 34.92 HYPERCHLORHYDRIA | 1 0.01 34.93 HYPERCHOLESTEROLAEMIA | 30 0.30 35.23 HYPERGLYCAEMIA | 1 0.01 35.24 HYPERLIPIDAEMIA | 34 0.34 35.58 HYPERPARATHYROIDISM | 1 0.01 35.59 HYPERPARATHYROIDISM SECONDARY | 2 0.02 35.61 HYPERPHOSPHATAEMIA | 2 0.02 35.63 HYPERPROLACTINAEMIA | 2 0.02 35.65 HYPERSENSITIVITY | 11 0.11 35.76 HYPERSOMNIA | 2 0.02 35.78 HYPERTENSION | 440 4.40 40.18 HYPERTENSIVE CARDIOMYOPATHY | 1 0.01 40.19 HYPERTHYROIDISM | 2 0.02 40.21 HYPERTONIC BLADDER | 1 0.01 40.22 HYPERTRIGLYCERIDAEMIA | 3 0.03 40.25 HYPERTROPHIC CARDIOMYOPATHY | 4 0.04 40.29 HYPERURICAEMIA | 23 0.23 40.52 HYPERVIGILANCE | 1 0.01 40.53 HYPOAESTHESIA | 1 0.01 40.54 HYPOALBUMINAEMIA | 1 0.01 40.55 HYPOCALCAEMIA | 1 0.01 40.56 HYPOGONADISM | 1 0.01 40.57 HYPOKALAEMIA | 2 0.02 40.59 HYPOPITUITARISM | 1 0.01 40.60 HYPOPROTEINAEMIA | 1 0.01 40.61 HYPOTENSION | 3 0.03 40.64 HYPOTHYROIDISM | 44 0.44 41.08 HYPOVITAMINOSIS | 2 0.02 41.10 HYPOVOLAEMIA | 1 0.01 41.11 HYSTERECTOMY | 2 0.02 41.13 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 14 0.14 41.27 ILEOSTOMY | 1 0.01 41.28 ILL-DEFINED DISORDER | 7 0.07 41.35 IMMUNE ENHANCEMENT THERAPY | 1 0.01 41.36 IMMUNE TOLERANCE INDUCTION | 1 0.01 41.37 IMMUNISATION | 1 0.01 41.38 IMMUNODEFICIENCY COMMON VARIABLE | 1 0.01 41.39 IMMUNOSUPPRESSANT DRUG THERAPY | 1 0.01 41.40 IMMUNOSUPPRESSION | 5 0.05 41.45 IMPAIRED GASTRIC EMPTYING | 1 0.01 41.46 IN VITRO FERTILISATION | 2 0.02 41.48 INDUCTION AND MAINTENANCE OF ANAESTHE.. | 1 0.01 41.49 INDUCTION OF ANAESTHESIA | 3 0.03 41.52 INFARCTION | 3 0.03 41.55 INFECTION | 11 0.11 41.66 INFECTION PROPHYLAXIS | 15 0.15 41.81 INFERTILITY | 2 0.02 41.83 INFERTILITY FEMALE | 1 0.01 41.84 INFLAMMATION | 5 0.05 41.89 INFLAMMATORY BOWEL DISEASE | 10 0.10 41.99 INFLAMMATORY CARCINOMA OF THE BREAST | 2 0.02 42.01 INFLUENZA | 2 0.02 42.03 INFLUENZA IMMUNISATION | 1 0.01 42.04 INGROWING NAIL | 1 0.01 42.05 INJURY | 2 0.02 42.07 INSOMNIA | 45 0.45 42.52 INSULIN-LIKE GROWTH FACTOR DECREASED | 1 0.01 42.53 INTENTIONAL OVERDOSE | 1 0.01 42.54 INTERSTITIAL LUNG DISEASE | 4 0.04 42.58 INTERVERTEBRAL DISC DEGENERATION | 2 0.02 42.60 INTERVERTEBRAL DISC PROTRUSION | 4 0.04 42.64 INTESTINAL OBSTRUCTION | 1 0.01 42.65 IRON DEFICIENCY | 1 0.01 42.66 IRON DEFICIENCY ANAEMIA | 1 0.01 42.67 IRON METABOLISM DISORDER | 2 0.02 42.69 IRON OVERLOAD | 21 0.21 42.90 IRRITABLE BOWEL SYNDROME | 2 0.02 42.92 ISCHAEMIC HEART DISEASE PROPHYLAXIS | 1 0.01 42.93 JOINT ARTHROPLASTY | 1 0.01 42.94 JUVENILE ARTHRITIS | 8 0.08 43.02 KERATITIS | 3 0.03 43.05 KIDNEY TRANSPLANT REJECTION | 2 0.02 43.07 KNEE ARTHROPLASTY | 7 0.07 43.14 KNEE OPERATION | 1 0.01 43.15 LABYRINTHITIS | 1 0.01 43.16 LACERATION | 2 0.02 43.18 LACRIMATION DECREASED | 1 0.01 43.19 LARGE INTESTINE CARCINOMA | 8 0.08 43.27 LAXATIVE SUPPORTIVE CARE | 2 0.02 43.29 LEIOMYOSARCOMA | 2 0.02 43.31 LEUKAEMIA | 1 0.01 43.32 LICE INFESTATION | 5 0.05 43.37 LIGAMENT OPERATION | 1 0.01 43.38 LIMB DISCOMFORT | 4 0.04 43.42 LIMB IMMOBILISATION | 4 0.04 43.46 LIPID METABOLISM DISORDER | 1 0.01 43.47 LIPIDS INCREASED | 1 0.01 43.48 LIPOSARCOMA METASTATIC | 1 0.01 43.49 LIVER AND SMALL INTESTINE TRANSPLANT | 15 0.15 43.64 LIVER DISORDER | 1 0.01 43.65 LIVER TRANSPLANT | 24 0.24 43.89 LOWER RESPIRATORY TRACT INFECTION | 3 0.03 43.92 LUMBAR SPINAL STENOSIS | 3 0.03 43.95 LUNG ADENOCARCINOMA | 8 0.08 44.03 LUNG ADENOCARCINOMA METASTATIC | 6 0.06 44.09 LUNG CANCER METASTATIC | 2 0.02 44.11 LUNG CARCINOMA CELL TYPE UNSPECIFIED .. | 9 0.09 44.20 LUNG DISORDER | 7 0.07 44.27 LUNG INFECTION | 2 0.02 44.29 LUNG NEOPLASM MALIGNANT | 19 0.19 44.48 LUNG TRANSPLANT | 8 0.08 44.56 LUPUS NEPHRITIS | 6 0.06 44.62 LYMPHOCYTIC LEUKAEMIA | 1 0.01 44.63 LYMPHOMA | 2 0.02 44.65 MACULAR DEGENERATION | 1 0.01 44.66 MACULOPATHY | 1 0.01 44.67 MAINTENANCE OF ANAESTHESIA | 3 0.03 44.70 MAJOR DEPRESSION | 4 0.04 44.74 MALARIA PROPHYLAXIS | 1 0.01 44.75 MALIGNANT ATROPHIC PAPULOSIS | 1 0.01 44.76 MALIGNANT MELANOMA | 12 0.12 44.88 MALIGNANT NEOPLASM OF ISLETS OF LANGE.. | 1 0.01 44.89 MALIGNANT SOFT TISSUE NEOPLASM | 2 0.02 44.91 MANIA | 8 0.08 44.99 MANTLE CELL LYMPHOMA | 4 0.04 45.03 MATERNAL EXPOSURE TIMING UNSPECIFIED | 6 0.06 45.09 MATERNAL THERAPY TO ENHANCE FOETAL LU.. | 1 0.01 45.10 MEDICAL DIET | 14 0.14 45.24 MENIERE'S DISEASE | 1 0.01 45.25 MENINGITIS FUNGAL | 2 0.02 45.27 MENOPAUSAL SYMPTOMS | 8 0.08 45.35 MENOPAUSE | 4 0.04 45.39 MENORRHAGIA | 19 0.19 45.58 MENSTRUAL CYCLE MANAGEMENT | 1 0.01 45.59 MENSTRUAL DISORDER | 3 0.03 45.62 MENSTRUATION IRREGULAR | 11 0.11 45.73 MENTAL DISORDER | 4 0.04 45.77 METABOLIC ACIDOSIS | 1 0.01 45.78 METASTASES TO BONE | 27 0.27 46.05 METASTASES TO LIVER | 1 0.01 46.06 METASTASES TO PROSTATE | 1 0.01 46.07 METASTASIS | 1 0.01 46.08 METASTATIC CARCINOID TUMOUR | 5 0.05 46.13 METASTATIC GASTRIC CANCER | 2 0.02 46.15 METASTATIC MALIGNANT MELANOMA | 18 0.18 46.33 METASTATIC NEOPLASM | 1 0.01 46.34 METASTATIC RENAL CELL CARCINOMA | 9 0.09 46.43 METRORRHAGIA | 1 0.01 46.44 MIGRAINE | 32 0.32 46.76 MIGRAINE PROPHYLAXIS | 1 0.01 46.77 MINERAL SUPPLEMENTATION | 3 0.03 46.80 MITRAL VALVE INCOMPETENCE | 1 0.01 46.81 MITRAL VALVE PROLAPSE | 1 0.01 46.82 MITRAL VALVE REPLACEMENT | 2 0.02 46.84 MOOD ALTERED | 3 0.03 46.87 MOOD SWINGS | 4 0.04 46.91 MUCOPOLYSACCHARIDOSIS VI | 1 0.01 46.92 MUCOSAL INFLAMMATION | 1 0.01 46.93 MULTIPLE ALLERGIES | 10 0.10 47.03 MULTIPLE FRACTURES | 1 0.01 47.04 MULTIPLE MYELOMA | 158 1.58 48.62 MULTIPLE SCLEROSIS | 264 2.64 51.26 MULTIPLE SCLEROSIS RELAPSE | 1 0.01 51.27 MULTIPLE-DRUG RESISTANCE | 1 0.01 51.28 MUSCLE RELAXANT THERAPY | 8 0.08 51.36 MUSCLE RUPTURE | 1 0.01 51.37 MUSCLE SPASMS | 9 0.09 51.46 MUSCLE SPASTICITY | 1 0.01 51.47 MUSCLE TIGHTNESS | 1 0.01 51.48 MUSCULOSKELETAL PAIN | 13 0.13 51.61 MUSCULOSKELETAL STIFFNESS | 1 0.01 51.62 MYALGIA | 6 0.06 51.68 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 6 0.06 51.74 MYELITIS | 1 0.01 51.75 MYELITIS TRANSVERSE | 1 0.01 51.76 MYELODYSPLASTIC SYNDROME | 16 0.16 51.92 MYELOFIBROSIS | 2 0.02 51.94 MYELOID LEUKAEMIA | 2 0.02 51.96 MYOCARDIAL INFARCTION | 6 0.06 52.02 MYOCARDIAL ISCHAEMIA | 5 0.05 52.07 MYOFASCIAL PAIN SYNDROME | 2 0.02 52.09 NASAL CONGESTION | 1 0.01 52.10 NASOPHARYNGITIS | 5 0.05 52.15 NAUSEA | 31 0.31 52.46 NECK PAIN | 2 0.02 52.48 NEOPLASM | 1 0.01 52.49 NEOPLASM MALIGNANT | 14 0.14 52.63 NEOPLASM PROPHYLAXIS | 1 0.01 52.64 NEPHRITIS | 1 0.01 52.65 NEPHROGENIC ANAEMIA | 10 0.10 52.75 NEPHROGENIC SYSTEMIC FIBROSIS | 2 0.02 52.77 NEPHROTIC SYNDROME | 2 0.02 52.79 NERVE INJURY | 2 0.02 52.81 NERVOUSNESS | 3 0.03 52.84 NEURALGIA | 6 0.06 52.90 NEUROBLASTOMA | 21 0.21 53.11 NEUROENDOCRINE CARCINOMA | 4 0.04 53.15 NEUROENDOCRINE TUMOUR | 10 0.10 53.25 NEUROGENIC BLADDER | 1 0.01 53.26 NEUROPATHY PERIPHERAL | 14 0.14 53.40 NEUTROPENIA | 3 0.03 53.43 NEUTROPHIL COUNT DECREASED | 2 0.02 53.45 NON-HODGKIN'S LYMPHOMA | 9 0.09 53.54 NON-SMALL CELL LUNG CANCER | 50 0.50 54.04 NON-SMALL CELL LUNG CANCER METASTATIC | 3 0.03 54.07 NON-SMALL CELL LUNG CANCER STAGE IV | 6 0.06 54.13 NUCLEAR MAGNETIC RESONANCE IMAGING | 4 0.04 54.17 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 4 0.04 54.21 NUTRITIONAL SUPPORT | 14 0.14 54.35 OBESITY | 3 0.03 54.38 OBSESSIVE-COMPULSIVE DISORDER | 4 0.04 54.42 OCULAR HYPERTENSION | 1 0.01 54.43 OEDEMA | 14 0.14 54.57 OEDEMA PERIPHERAL | 6 0.06 54.63 OESOPHAGEAL ADENOCARCINOMA | 4 0.04 54.67 OESOPHAGEAL CANDIDIASIS | 1 0.01 54.68 OESOPHAGEAL DISORDER | 1 0.01 54.69 OESOPHAGITIS | 1 0.01 54.70 OESTROGEN THERAPY | 1 0.01 54.71 OFF LABEL USE | 14 0.14 54.85 ONYCHOMYCOSIS | 2 0.02 54.87 OPEN ANGLE GLAUCOMA | 3 0.03 54.90 OPPORTUNISTIC INFECTION PROPHYLAXIS | 2 0.02 54.92 OPPOSITIONAL DEFIANT DISORDER | 1 0.01 54.93 ORAL CANDIDIASIS | 1 0.01 54.94 ORAL CONTRACEPTION | 19 0.19 55.13 ORAL HERPES | 1 0.01 55.14 ORAL PAIN | 1 0.01 55.15 ORGANISING PNEUMONIA | 1 0.01 55.16 OROPHARYNGEAL PAIN | 6 0.06 55.22 OSTEITIS | 5 0.05 55.27 OSTEOARTHRITIS | 16 0.16 55.43 OSTEOMYELITIS | 1 0.01 55.44 OSTEOPENIA | 12 0.12 55.56 OSTEOPOROSIS | 178 1.78 57.34 OSTEOPOROSIS POSTMENOPAUSAL | 9 0.09 57.43 OSTEOPOROSIS PROPHYLAXIS | 1 0.01 57.44 OSTEOPOROTIC FRACTURE | 1 0.01 57.45 OVARIAN CANCER | 9 0.09 57.54 OVARIAN CANCER RECURRENT | 2 0.02 57.56 OVARIAN CANCER STAGE IV | 1 0.01 57.57 OVARIAN CYST | 3 0.03 57.60 OVERWEIGHT | 1 0.01 57.61 OVULATION INDUCTION | 3 0.03 57.64 PAIN | 169 1.69 59.33 PAIN IN EXTREMITY | 10 0.10 59.43 PAIN MANAGEMENT | 13 0.13 59.56 PAIN OF SKIN | 1 0.01 59.57 PALLIATIVE CARE | 2 0.02 59.59 PANCREAS TRANSPLANT | 4 0.04 59.63 PANCREATIC CARCINOMA | 3 0.03 59.66 PANCREATIC NEUROENDOCRINE TUMOUR | 3 0.03 59.69 PANCREATIC NEUROENDOCRINE TUMOUR META.. | 1 0.01 59.70 PANCREATITIS | 4 0.04 59.74 PANCREATITIS CHRONIC | 2 0.02 59.76 PANIC ATTACK | 10 0.10 59.86 PANIC DISORDER | 4 0.04 59.90 PAPILLOMA VIRAL INFECTION | 1 0.01 59.91 PARALYSIS | 1 0.01 59.92 PARANOIA | 1 0.01 59.93 PARAPLEGIA | 1 0.01 59.94 PARKINSON'S DISEASE | 35 0.35 60.29 PARKINSONISM | 1 0.01 60.30 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA | 5 0.05 60.35 PELVIC PAIN | 2 0.02 60.37 PEMPHIGUS | 1 0.01 60.38 PERCUTANEOUS CORONARY INTERVENTION | 3 0.03 60.41 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 7 0.07 60.48 PERIPHERAL ISCHAEMIA | 2 0.02 60.50 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED | 3 0.03 60.53 PERIPHERAL VASCULAR DISORDER | 2 0.02 60.55 PERITONEAL DIALYSIS | 23 0.23 60.78 PERTUSSIS | 2 0.02 60.80 PHARYNGITIS | 3 0.03 60.83 PHLEBITIS | 2 0.02 60.85 PITUITARY TUMOUR BENIGN | 2 0.02 60.87 PITUITARY-DEPENDENT CUSHING'S SYNDROME | 1 0.01 60.88 PITYRIASIS | 1 0.01 60.89 PLASMACYTOMA | 3 0.03 60.92 PLATELET AGGREGATION INHIBITION | 1 0.01 60.93 PLATELET COUNT DECREASED | 1 0.01 60.94 PLEURISY | 5 0.05 60.99 PNEUMONIA | 13 0.13 61.12 PNEUMONIA ASPIRATION | 5 0.05 61.17 PNEUMONIA FUNGAL | 2 0.02 61.19 PNEUMONIA MYCOPLASMAL | 1 0.01 61.20 PNEUMONITIS | 1 0.01 61.21 POLLAKIURIA | 3 0.03 61.24 POLYCYSTIC OVARIES | 15 0.15 61.39 POLYCYTHAEMIA VERA | 1 0.01 61.40 POLYMYALGIA RHEUMATICA | 2 0.02 61.42 POLYURIA | 1 0.01 61.43 POOR PERIPHERAL CIRCULATION | 1 0.01 61.44 POOR QUALITY SLEEP | 2 0.02 61.46 POST COITAL CONTRACEPTION | 41 0.41 61.87 POST-TRAUMATIC EPILEPSY | 1 0.01 61.88 POST-TRAUMATIC STRESS DISORDER | 3 0.03 61.91 POSTOPERATIVE CARE | 4 0.04 61.95 PRECOCIOUS PUBERTY | 1 0.01 61.96 PREGNANCY | 1 0.01 61.97 PREMATURE BABY | 2 0.02 61.99 PREMATURE LABOUR | 1 0.01 62.00 PREMEDICATION | 55 0.55 62.55 PREMENSTRUAL SYNDROME | 49 0.49 63.04 PRENATAL CARE | 1 0.01 63.05 PREOPERATIVE CARE | 2 0.02 63.07 PRIMARY HYPOTHYROIDISM | 1 0.01 63.08 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS | 1 0.01 63.09 PROCEDURAL PAIN | 5 0.05 63.14 PROCTALGIA | 1 0.01 63.15 PRODUCT USED FOR UNKNOWN INDICATION | 1,939 19.39 82.54 PROLACTINOMA | 1 0.01 82.55 PROMOTION OF PERIPHERAL CIRCULATION | 1 0.01 82.56 PROPHYLAXIS | 167 1.67 84.23 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 19 0.19 84.42 PROPHYLAXIS AGAINST GRAFT VERSUS HOST.. | 13 0.13 84.55 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 21 0.21 84.76 PROPHYLAXIS OF NAUSEA AND VOMITING | 7 0.07 84.83 PROPHYLAXIS OF NEURAL TUBE DEFECT | 1 0.01 84.84 PROSTATE CANCER | 20 0.20 85.04 PROSTATE CANCER METASTATIC | 24 0.24 85.28 PROSTATE INFECTION | 2 0.02 85.30 PROSTATIC DISORDER | 2 0.02 85.32 PROSTATIC OPERATION | 1 0.01 85.33 PROSTATIC SPECIFIC ANTIGEN INCREASED | 1 0.01 85.34 PROSTATITIS | 2 0.02 85.36 PROSTATOMEGALY | 2 0.02 85.38 PRURITUS | 8 0.08 85.46 PSEUDOMONAS INFECTION | 2 0.02 85.48 PSORIASIS | 46 0.46 85.94 PSORIATIC ARTHROPATHY | 27 0.27 86.21 PSYCHIATRIC SYMPTOM | 1 0.01 86.22 PSYCHOTIC DISORDER | 15 0.15 86.37 PULMONARY ARTERIAL HYPERTENSION | 43 0.43 86.80 PULMONARY EMBOLISM | 2 0.02 86.82 PULMONARY FIBROSIS | 1 0.01 86.83 PULMONARY HYPERTENSION | 22 0.22 87.05 PULMONARY TUBERCULOSIS | 10 0.10 87.15 PYELONEPHRITIS | 3 0.03 87.18 PYREXIA | 9 0.09 87.27 RABIES | 1 0.01 87.28 RAPID EYE MOVEMENTS SLEEP ABNORMAL | 1 0.01 87.29 RASH | 3 0.03 87.32 RECTAL ADENOMA | 2 0.02 87.34 RECTAL CANCER | 16 0.16 87.50 RECTAL CANCER METASTATIC | 7 0.07 87.57 RECTAL CANCER RECURRENT | 2 0.02 87.59 RED BLOOD CELL COUNT DECREASED | 1 0.01 87.60 REFLUX GASTRITIS | 2 0.02 87.62 REFUSAL OF TREATMENT BY PATIENT | 1 0.01 87.63 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 19 0.19 87.82 RELAXATION THERAPY | 1 0.01 87.83 RENAL CANCER | 12 0.12 87.95 RENAL CANCER METASTATIC | 2 0.02 87.97 RENAL CELL CARCINOMA | 16 0.16 88.13 RENAL CYST | 1 0.01 88.14 RENAL FAILURE | 2 0.02 88.16 RENAL FAILURE ACUTE | 2 0.02 88.18 RENAL FAILURE CHRONIC | 7 0.07 88.25 RENAL IMPAIRMENT | 1 0.01 88.26 RENAL TRANSPLANT | 47 0.47 88.73 RESPIRATORY DISORDER | 2 0.02 88.75 RESPIRATORY FAILURE | 1 0.01 88.76 RESPIRATORY TRACT CONGESTION | 3 0.03 88.79 RESPIRATORY TRACT INFECTION | 6 0.06 88.85 RESTLESS LEGS SYNDROME | 3 0.03 88.88 RETINAL VEIN OCCLUSION | 2 0.02 88.90 RETINOBLASTOMA | 20 0.20 89.10 RHABDOMYOSARCOMA | 18 0.18 89.28 RHEUMATOID ARTHRITIS | 280 2.80 92.08 RHINITIS | 2 0.02 92.10 RHINITIS ALLERGIC | 1 0.01 92.11 RHINOPLASTY | 1 0.01 92.12 RICHTER'S SYNDROME | 5 0.05 92.17 RIGHT VENTRICULAR FAILURE | 1 0.01 92.18 ROSACEA | 2 0.02 92.20 ROUTINE HEALTH MAINTENANCE | 13 0.13 92.33 SALIVARY HYPERSECRETION | 1 0.01 92.34 SARCOIDOSIS | 5 0.05 92.39 SARCOMA | 1 0.01 92.40 SCAN | 1 0.01 92.41 SCAN MYOCARDIAL PERFUSION | 1 0.01 92.42 SCHIZOAFFECTIVE DISORDER | 17 0.17 92.59 SCHIZOPHRENIA | 92 0.92 93.51 SCHIZOPHRENIA, PARANOID TYPE | 5 0.05 93.56 SCIATICA | 7 0.07 93.63 SCLERODERMA | 3 0.03 93.66 SCRATCH | 1 0.01 93.67 SEASONAL ALLERGY | 2 0.02 93.69 SECRETION DISCHARGE | 1 0.01 93.70 SEDATION | 1 0.01 93.71 SEDATIVE THERAPY | 1 0.01 93.72 SENILE OSTEOPOROSIS | 1 0.01 93.73 SEPSIS | 3 0.03 93.76 SERUM FERRITIN INCREASED | 1 0.01 93.77 SHORT-BOWEL SYNDROME | 1 0.01 93.78 SICKLE CELL ANAEMIA | 3 0.03 93.81 SINUS CONGESTION | 2 0.02 93.83 SINUS DISORDER | 1 0.01 93.84 SINUS HEADACHE | 2 0.02 93.86 SINUSITIS | 12 0.12 93.98 SKELETAL INJURY | 2 0.02 94.00 SKIN LESION | 1 0.01 94.01 SKIN WRINKLING | 1 0.01 94.02 SLEEP DISORDER | 31 0.31 94.33 SMALL CELL LUNG CANCER EXTENSIVE STAGE | 1 0.01 94.34 SMALL INTESTINE CARCINOMA | 1 0.01 94.35 SMALL INTESTINE TRANSPLANT | 3 0.03 94.38 SMOKING CESSATION THERAPY | 33 0.33 94.71 SPINAL OSTEOARTHRITIS | 7 0.07 94.78 SPLENIC MARGINAL ZONE LYMPHOMA | 1 0.01 94.79 SPONDYLITIS | 3 0.03 94.82 SPONDYLOARTHROPATHY | 2 0.02 94.84 SPORTS INJURY | 1 0.01 94.85 STAPHYLOCOCCAL INFECTION | 3 0.03 94.88 STATUS EPILEPTICUS | 4 0.04 94.92 STEM CELL TRANSPLANT | 1 0.01 94.93 STENT PLACEMENT | 2 0.02 94.95 STRESS | 2 0.02 94.97 STRIDOR | 1 0.01 94.98 SUICIDE ATTEMPT | 76 0.76 95.74 SUPPLEMENTATION THERAPY | 43 0.43 96.17 SURGERY | 1 0.01 96.18 SWELLING | 4 0.04 96.22 SWELLING FACE | 1 0.01 96.23 SYSTEMIC LUPUS ERYTHEMATOSUS | 10 0.10 96.33 TACHYCARDIA | 1 0.01 96.34 TARDIVE DYSKINESIA | 1 0.01 96.35 TEMPORAL LOBE EPILEPSY | 4 0.04 96.39 TEMPOROMANDIBULAR JOINT SYNDROME | 1 0.01 96.40 TENDONITIS | 1 0.01 96.41 TENSION HEADACHE | 2 0.02 96.43 THALASSAEMIA | 2 0.02 96.45 THROMBOCYTOPENIA | 1 0.01 96.46 THROMBOSIS | 1 0.01 96.47 THROMBOSIS PROPHYLAXIS | 32 0.32 96.79 THYROID CANCER | 2 0.02 96.81 THYROID CANCER METASTATIC | 1 0.01 96.82 THYROID DISORDER | 12 0.12 96.94 THYROIDECTOMY | 1 0.01 96.95 TOBACCO USER | 2 0.02 96.97 TONIC CLONIC MOVEMENTS | 2 0.02 96.99 TONSILLITIS | 4 0.04 97.03 TOOTHACHE | 1 0.01 97.04 TORSADE DE POINTES | 1 0.01 97.05 TOXICITY TO VARIOUS AGENTS | 1 0.01 97.06 TRACHEITIS | 2 0.02 97.08 TRANSIENT ISCHAEMIC ATTACK | 5 0.05 97.13 TRANSITIONAL CELL CARCINOMA | 3 0.03 97.16 TRANSPLANT | 5 0.05 97.21 TRANSPLANT REJECTION | 3 0.03 97.24 TREMOR | 9 0.09 97.33 TRIGEMINAL NEURALGIA | 1 0.01 97.34 TUBERCULOSIS | 8 0.08 97.42 TUMOUR PAIN | 4 0.04 97.46 TYPE 1 DIABETES MELLITUS | 11 0.11 97.57 TYPE 2 DIABETES MELLITUS | 124 1.24 98.81 ULCER | 5 0.05 98.86 UNEVALUABLE EVENT | 5 0.05 98.91 UPPER RESPIRATORY TRACT INFECTION | 2 0.02 98.93 UPPER RESPIRATORY TRACT INFLAMMATION | 8 0.08 99.01 UPPER-AIRWAY COUGH SYNDROME | 1 0.01 99.02 URINARY INCONTINENCE | 5 0.05 99.07 URINARY RETENTION | 1 0.01 99.08 URINARY TRACT DISORDER | 1 0.01 99.09 URINARY TRACT INFECTION | 18 0.18 99.27 UTERINE LEIOMYOMA | 1 0.01 99.28 UVEITIS | 1 0.01 99.29 VAGINAL INFECTION | 1 0.01 99.30 VAGINITIS BACTERIAL | 1 0.01 99.31 VASCULITIS | 1 0.01 99.32 VENOUS THROMBOSIS | 2 0.02 99.34 VENTRICULAR FIBRILLATION | 2 0.02 99.36 VENTRICULAR TACHYCARDIA | 2 0.02 99.38 VERTIGO | 2 0.02 99.40 VESTIBULAR NEURONITIS | 5 0.05 99.45 VIRAL HEPATITIS CARRIER | 1 0.01 99.46 VIRAL INFECTION | 1 0.01 99.47 VISION BLURRED | 1 0.01 99.48 VITAMIN B12 DEFICIENCY | 1 0.01 99.49 VITAMIN D | 1 0.01 99.50 VITAMIN D DEFICIENCY | 3 0.03 99.53 VITAMIN SUPPLEMENTATION | 8 0.08 99.61 VOGT-KOYANAGI-HARADA SYNDROME | 3 0.03 99.64 VOMITING | 12 0.12 99.76 VULVOVAGINAL CANDIDIASIS | 3 0.03 99.79 VULVOVAGINAL DRYNESS | 4 0.04 99.83 VULVOVAGINAL PRURITUS | 1 0.01 99.84 WEIGHT DECREASED | 6 0.06 99.90 WHEEZING | 5 0.05 99.95 WISKOTT-ALDRICH SYNDROME | 1 0.01 99.96 WOUND COMPLICATION | 1 0.01 99.97 WOUND INFECTION | 1 0.01 99.98 X-RAY | 2 0.02 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015